Since the first introduction of sodium iodide I-131 for use with thyroid patients almost 80
years ago, more than 50 radiopharmaceuticals have reached the markets for a wide range …

Early diagnosis is essential for completely eradicating skin cancer and maximizing patients'
clinical benefits. Emerging optical imaging modalities such as reflectance confocal …

Ultrasmall nanoparticles (USNs)(nanoparticles with hydrodynamic diameter< 10 nm) are
being widely developed pre‐clinically and started to emerge in clinical trials over the last …

The precise delivery of cytotoxic radiation to cancer cells through the combination of a
specific targeting vector with a radionuclide for targeted radionuclide therapy (TRT) has …

Ovarian cancer is the most deadly gynecologic malignancy, and its incidence is gradually
increasing. Despite improvements after treatment, the results are unsatisfactory and survival …

High and sustained renal radioactivity accumulation is a major challenge in peptide-based
radionuclide imaging and therapy. However, neutral endopeptidase (NEP)-based enzymatic …

With peptides increasingly favored as drugs, natural product motifs, namely the
tryptathionine staple, found in amatoxins and phallotoxins, and the 2, 2'‐bis‐indole found in …

Malignant melanoma is accounting for most of skin cancer-associated mortality. The
incidence of melanoma increased every year worldwide especially in western countries …

Purpose Cancer treatment with alpha-emitter-based radioligand therapies (α-RLTs)
demonstrates promising tumor responses. Radiolabeled peptides are filtered through …

Recently, the substance P (SP)/neurokinin-1 receptor (NK-1R) system has been found to be
involved in various human pathophysiological disorders including the symptoms of …